# Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD

> **NCT01089959** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Southern Arizona VA Health Care System** · enrollment: 20 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** esomeprazole

## Key facts

- **NCT ID:** NCT01089959
- **Lead sponsor:** Southern Arizona VA Health Care System
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-03
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01089959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01089959, "Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01089959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*